Ubiquitin-specific protease 22: a novel molecular biomarker in cervical cancer prognosis and therapeutics

By Yang Meng   Liu Yun-Duo   Wang Yan-Ying   Liu Tian-Bo   Ge Ting-Ting   Lou Ge  

Tumor Biology, Vol. 35, Iss. 2, 2014-02 ,pp. : 929-934

Springer Publishing Company

Access to resources Recommend Favorite

Reduced ubiquitin-specific protease 9X expression induced by RNA interference inhibits the bioactivity of hepatocellular carcinoma cells

By                

Oncology Letters, Vol. 10, Iss. 1, 2015-01 ,pp. : 268-272

Spandidos Publications

Access to resources Recommend Favorite

Current Status of Tumor M2 Pyruvate Kinase (Tumor M2-PK) as a Biomarker of Gastrointestinal Malignancy

By Hathurusinghe Harsha  

Annals of Surgical Oncology, Vol. 14, Iss. 10, 2007-10 ,pp. : 2714-2720

Springer Publishing Company

Access to resources Recommend Favorite

Ubiquitin-specific proteases as cancer drug targets

By Sippl Wolfgang   Collura Vincent   Colland Fréédééric  

Future Oncology, Vol. 7, Iss. 5, 2011-05 ,pp. : 619-632

Future Medicine

Access to resources Recommend Favorite

The combination of the expression of hexokinase 2 and pyruvate kinase M2 is a prognostic marker in patients with pancreatic cancer

By                                  

Molecular and Clinical Oncology, Vol. 3, Iss. 3, 2015-01 ,pp. : 563-571

Science Publishers

Access to resources Recommend Favorite